Related Experiment Video
Updated: Jan 15, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Swiss Diabetes and Technology recommendations
Giacomo Gastaldi1, Lia Bally2, Marie-Anne Burckhardt3
1DiaCenTRE-Hirslanden Geneva SA, Transplant Unit, Department of Surgery, Faculty of Medicine, University of Geneva and Geneva University Hospitals (HUG), Geneva, Switzerland.
Swiss Medical Weekly
|October 16, 2025
Summary
Switzerland
Area of Science:
- Diabetes Technology
- Medical Devices
- Digital Health
Background:
- Technological advancements are transforming diabetes mellitus management.
- Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery (AID) are standards of care for type 1 diabetes in Switzerland.
- A comprehensive overview of available diabetes technologies in Switzerland is needed.
Purpose of the Study:
- To provide a comprehensive overview of diabetes-related technologies in Switzerland.
- To detail technical specifications, indications, compatibility, and reimbursement.
- To offer guidance for implementation across diverse populations and special considerations.
Main Methods:
- Review of current diabetes technologies available in Switzerland.
- Analysis of technical specifications, indications for use, and compatibility.
- Examination of reimbursement regulations and practical implementation guidance.
- Inclusion of recommendations for special populations and emerging technologies like telemedicine.
Main Results:
- Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery (AID) systems are crucial for type 1 diabetes, especially in youth.
- These technologies improve glycaemic control and reduce complications in pregnancy and older adults.
- Telemedicine and remote monitoring offer accessibility but present challenges in digital literacy, interoperability, and data protection.
- Structured education programs are essential for effective and safe use of diabetes technology.
Conclusions:
- Effective and equitable use of diabetes technology in Switzerland requires comprehensive guidance.
- Recommendations aim to support healthcare providers, patients, and policymakers in optimizing diabetes care.
- Integration of technology necessitates structured education for successful self-management and improved outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
01:22Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
01:15Hypoglycemia and Glucagon
826
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
826
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
01:29Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K